Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of recombinant HPV6/11 bivalent vaccine (E. coli–expressed)
CTR20140712Phase 2Active
- Sponsor
- Xiamen University
- Start
- Mar 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human papillomavirus type 6/11 bivalent vaccine in human papillomavirus infection, anogenital warts, sponsored by Xiamen University. Started Mar 2016; status: active.
02
Drugs
recombinant human papillomavirus type 6/11 bivalent vaccine
03
Conditions
human papillomavirus infectionanogenital warts
Beyond the preview
Go deeper on CTR20140712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140712.